Background Colorectal cancer (CRC) screening using faecal occult blood or faecal immunological testing (FOBT/FIT) involves completion of a screening test-then if required a follow-up diagnostic test.
Introduction
Adherence is a fundamental facet of any screening programme, predicting its long-term effectiveness.
1,2 Measures of adherence differ between programmes but generally cover the consistent and up-to-date use of the best practice screening regimen in the eligible population-or more simply not having any need further need of screening.
1 Faecal occult blood (FOBT) or faecal immunological testing (FIT) is recommended globally for screening for colorectal cancer (CRC), the third most common cancer internationally-with~1.4 new cases diagnosed per year. 3 These screening regimens involve multiple stages, with an initial screening test followed by a diagnostic test if the first test is positive (from here on referred to as 'the diagnostic test'). A patient must therefore pass through all necessary stages in order to be adherent.
There is evidence of incomplete follow-up after testing in general in primary care and cancer screening as a whole, 4, 5 although there has been less focus on FOBT/FIT. One review found, in randomised trials, that between 83 and This study investigated characteristics behind, reasons for and interventions to reduce incomplete diagnostic testing after a positive FOBT/FIT in CRC screening, focusing on:
(1) cross-sectional patient patterns in diagnostic testing after a FOBT/FIT; (2) clinician and health system factors associated with diagnostic testing after a FOBT/FIT; (3) underlying factors behind incomplete diagnostic testing -including reported reasons for non-attendance and underlying causes; and (4) interventions to improve diagnostic testing after a positive FOBT/FIT.
Methods
I conducted systematic review of published literature, searching EMBASE , MEDLINE (PubMed) (January 1966 (January -2016 ) and the Cochrane Library including the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE). I additionally ran searches in Google Scholar, including both published and other technical literature. Searches were restricted to the English language: I searched 'all fields' in MEDLINE, and 'keyword, title, abstract' in EMBASE and the Cochrane Library. I used two strings of search terms, presented in Supplementary data, Appendix 1, including the following: 'f(a)ecal occult blood,' 'f(a)ecal immunological,' test*, positive, 'follow-up,' colonoscopy, sigmoidoscopy, 'complete diagnostic evaluation,' compliance/ comply, attend*, uptake, 'non-completion,' accept*, adhere*, participat*, refer*. I performed searches on 13th April, 2016. In addition, I scanned references of included studies for further relevant articles.
Articles were included from the search if they (i) included participants free from CRC and focused on screening for CRC using FOBT/FIT; or included clinicians or others involved in this screening-use of FOBT/FIT for other purposes were excluded; (ii) within this group, studied diagnostic testing in those with a positive screening test-using the recommended test (usually colonoscopy); (iii) included as an outcome the rate of diagnostic testing, patient intention to complete diagnostic testing, clinician intentions to offer diagnostic testing, documented reasons for incomplete diagnostic testing and barriers from a patient or health care perspective. I extracted data into pre-prepared pro forma, collecting outcomes-percentage rates of diagnostic testing (either by patient or intervention group); adjusted odds ratios or relative risks between groups; reasons for incomplete diagnostic testing, listing, quantifying and presenting qualitative data-and other study characteristics.
I present patient characteristics associated with diagnostic testing as a range of relative risks-adjusted risk (or odds ratio) if given or unadjusted. I present results of intervention studies individually, not combining these due to the variation in interventions; and report other outcomes, such as qualitative data, descriptively. The report follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement.
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Results
A total of 1435 articles published in English were retrieved after removing duplicates (Fig. 1) . A total of 68 articles met inclusion criteria, from 63 unique studies. Within the four pre-defined areas 37 articles explored patient patterns in diagnostic testing, seven investigated clinician and structural factors, 23 underlying factors behind non-adherence and 15 either employed or evaluated interventions to improve diagnostic testing rates (not mutually exclusive). Studies were carried out in 12 countries, Australia, Brunei, Canada, China, France, Japan, the Republic of Ireland, the Republic of Korea, Spain, Taiwan, the UK and the USA. Data collection was from 1986 to 2014. 
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Studies relevant to the first three research questions were observational, with 17 retrospective cohort studies, 10 prospective cohorts (one matched), 11 cross-sectional (including four questionnaire studies), three ecological, two repeat cross-sectional, one time-series, one case-control, two qualitative and two mixed methods studies (retrospective cohort with quantitative; retrospective cohort with questionnaire). Of studies of interventions, seven were time-series, four randomised controlled trails (including two cluster randomised), two cross-sectional and one mixed methods studies (timeseries and qualitative).
Cross-sectional patient patterns in diagnostic testing
Overall, 37 studies reported patient characteristics associated with diagnostic testing after a positive FOBT/FIT. The results from these are summarised in Table 1 .
Socio-demographic factors
There is no difference in diagnostic testing by sex. A number of studies examine the association with age: [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [40] [41] [42] [43] [44] although there was no definitive pattern, more studies find higher rates in younger compared with older participants, 15, 16, 19, 29, 32, 43, 44 than the converse. 23, 24, 27, 42, 43 Minority ethnic groups have lower diagnostic testing rates, 13, 17, 22, 24, 26, 27, 29, 31, 33, 34, 43, 45, 46 with evidence from south Asian groups in the UK, non-White groups in the US and indigenous populations in Australia (RR = 0.31-0.94), as do those whose first language is not the predominant language 23, 24, 27 and immigrants. 18, 47 Fifteen studies examined associations between socioeconomic position (SEP) and diagnostic testing: eight of nine significant results showed higher rates in higher SEP groups (RR highest versus lowest fifth: 0.53-0.92). 13, 15, 21, [27] [28] [29] 44 Remoteness 20,27 and low population density 18, 29, 44 have also been associated with low diagnostic testing rates.
Lifestyle and health care factors Poor health behaviours-smoking, alcohol consumption (high) and exercise (low), have been associated with low diagnostic testing rates, but in a single study. 45 Severe disability; 27 hospital admission following the screening test 18 and, in one of two studies examining it, higher health care use (outpatient visits) have also been linked 17 -although chronic co-morbidity had no association. 17, 18, 24, 33, 48 In systems with a mix of health insurance status, studies in the US and R. of Korea, those with health insurance have higher diagnostic testing rates. 16, 24, 43 CRC and screening factors A good CRC screening history is associated with higher diagnostic testing rates: those with a previous FOBT (RR = 1.08-2.33) 21, 41 and consistent FOBT attenders (RR = 2.33) 40 more likely to attend. Family history of CRC 14 and conducting the test in a health care setting 21, 49 increase diagnostic testing-whilst recent colonoscopy (a valid exclusion in many programmes) is a significant marker of low rates. 18, 43 In testing regimes using test kits with multiple 'windows', the greater number positive the higher chance of the patient attending a diagnostic test. 14, 17, 18 Clinician, health care factors and diagnostic testing rates Seven studies explored clinician characteristics and structural aspects of care or the screening programme that were associated with increased diagnostic testing rates. 18 ,21,38,49-52 Table 2 lists the facets of care/ the clinician shown to have positive associations with diagnostic testing across the studies.
Underlying factors behind incomplete diagnostic testing
Medical record audit Methods varied in studies examining underlying factors behind incomplete diagnostic testing-including in the depth in which they looked. The most superficial method was presenting reasons stated in medical records for patients not receiving diagnostic testing (Table 3) . 13, 14, 17, 23, 24, 27, 29, 36, [53] [54] [55] [56] [57] [58] The most common legitimate reasons were having a recent colonoscopy (1.3-14.9% of eligible patients), being medically unfit (0.8-8.1%) or already being under surveillance (1.6-3.3%). Patient refusal /non-attendance ranged from 2.2 to 10.8%.
Validity of patient exclusion
Studies have evaluated whether documented reasons for incomplete diagnostic testing are valid based on current guidance (an estimate of 43% valid in one study). 58 Legitimate clinician reasons for non-referral were recent colonoscopy and medical contraindication. [56] [57] [58] Inappropriate reasons include results from a non-diagnostic test (i.e. being satisfied with these results-not the correct diagnostic test); incorrect belief medical history or medication use exempted patient; non-adherence to diet; belief about eligibility (insufficient positive FOBT results, having no family history of CRC or outside age range), and belief that diet or underlying health issue caused screening result. [56] [57] [58] Patient-focused reasons included death, leaving their general practice, being out of the country, other health priorities, patient error, practical barriers, unwillingness to undergo colonoscopy and having dependents/other commitments. 58, 59 Quantifying these, one study found 30% of non-attendees did not want the test, 23% had other commitments, 17% felt the screen test must be a false positive and 15% had another health issue that took priority. 58, 59 Qualitative and questionnaire studies Another set of studies went beyond using routine dataactively examining patient factors behind incomplete diagnostic testing. Worry over CRC can increase the propensity to attend a diagnostic test, 14 although another study showed non-attendees had raised CRC-specific worry and situational anxiety (statistical significance not reported). 60 Questionnaires Data not reported in study. SEP = socioeconomic position; BMI = body mass index; N/S = non-significant; CRC = colorectal cancer; FOBT = faecal occult blood test.
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in matched cohorts-diagnostic test compliant with noncompliant-showed perceived susceptibility (to CRC), casual personality (negatively) and exposure to information (as a cue) were associated with compliance. 61 Health beliefs and health knowledge are associated with diagnostic testing rates (or intention to attend). Knowledge of CRC-its prevention, screening and symptoms; understanding benefits of early diagnosis; belief that screening improves CRC outcomes and faith in medical advice have all been associated with higher rates, [62] [63] [64] with a major reason to attend to ensure the patient did not have cancer. 64 Factors associated with lower diagnostic testing rates include embarrassment about colonoscopy, misconceptions about requirements (e.g. eligible age and symptoms), being uncomfortable talking about CRC, being too busy, having other priorities, fearing the pain, fearing finding cancer and misconceptions about cost. 55, [62] [63] [64] [65] Patients can fear colonoscopy due to pain and potential adverse effects-with one study quantifying this as over twice as common as any other barrier 64 -whilst previous bad experiences of colonoscopy is also important. 55 There may be a mismatch between clinician and patient beliefs: in one study clinicians believed patients would be more worried about the screening test, but in fact they had greater fear of the diagnostic test. 65 Factors behind ethnic differences Exploring differences in diagnostic testing rates by ethnicity, interviews highlighted non-English speakers in the US had barriers (to colonoscopy), including transport, understanding, and costs. 24 A UK study found no direct factor behind incomplete diagnostic testing in those of South Asian background, although literacy deficiencies (lack of knowledge of procedures and reliance on family for communication) and availability to attend were important. 26 A US focus group suggested patients and health care providers felt the location of colonoscopy and availability of evening/weekend appointments impacted whether uninsured black patients received diagnostic testing. 66 Interventions to improve diagnostic testing rates Thirteen studies implemented or evaluated interventions to increase diagnostic testing after a positive FOBT/FIT (Table 4) , 44, [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] all set within existing screening programmes. 71, 73, 77, 79 Of the four RCTs, one, in the US veteran's health administration (VHA), introduced automatic notification to the colonoscopy provider (gastroenterology department) of positive FOBTs, in addition to notifications to the primary care team. 71 The second used an educational package for primary care providers in a US managed care organisation (MCO), containing a training session, follow-up telephone contact and ongoing performance data. The third introduced a 'nurse navigator', a single screening specialist assigned to each patient following positive FOBT in a US MCO: they supported logistics, booking appointments, etc., and provided counselling to support diagnostic testing. 77 The fourth trial, in Italy, allocated FIT positive patients to different methods of diagnostic test invite, namely first invite by telephone or post, with non-responders reminded by post, general practitioner or screening specialist consulation. 79 The 'nurse navigator' significantly increased diagnostic testing rates (AOR = 1.63 (1.01-2.55)); 77 as did a second invite to follow-up through a screening specialist consultation (AOR = 1.33 (1.01-1.76))-with GP consultation not significantly different to a written invite (AOR = 0.82 (0.59-1.14)). 79 Eight studies used a 'before-after' (time-series) methodology to examine the impact of a change in an existing screening programme, 44, 67, 69, 70, [74] [75] [76] 78, 80 six of these were in MCOs in the US (five in the VHA); 67, 69, 70, [74] [75] [76] 80 one in the UK BCSP 78 and one in Ontario's ColonCheck programme. 44 Interventions were namely, an automated message to primary care about positive FOBTs, with information on diagnostic testing; introducing diagnostic testing guidelines; weekly data reporting from labs of b Due to practice drop out, the outcomes were not combined within intervention and control groups for mathematical reasons.
positive FOBT results to colonoscopy providers; offering the screening specialist appointment (the pre-colonoscopy consultation) by telephone in addition to face-to-face; two multi-faceted interventions using quality improvement methods; introducing an educational element to an existing primary care reminder system; directly informing patients of positive results from the lab, in addition to their primary care provider; and modifying an existing EMR reminderbetter targeting it at a patient's primary care clinician. Results are presented in Table 4 . Three interventions, an automated reminder system in EMRs, one quality improvement initiative, and weekly reports to colonoscopy providers did not significantly increase overall diagnostic testing rates, but significantly increased speed of testing. 69, 70, 74, 75 Five of the other six interventions significantly improved rates. 44, 67, 76, 78, 80 A one off nurse audit highlighted incomplete diagnostic testing, increasing coverage in a closed cohort-although significance was not reported. 68 Another study developed an EMR reminder system for people with positive FOBT results and no recorded diagnostic test, although merely presented the number it would highlight-not its impact on care. 72 
Discussion
Main findings of this study
Rates of diagnostic testing following a positive FOBT/FIT can be lower in minority ethnic and low SEP groups. For minority ethnic groups this may be driven by language barriers-highlighted by associations between first language and testing rates: language differences limit understanding and in two phase testing inhibit completion. 81 Minority ethnic groups may also be exposed to specific practical barrierssuch as availability to meet appointments, reliance on others for translation and access to testing facilities. Low SEP groups have low health literacy 82 and can face greater practical barriers, such as indirect economic barriers (e.g. forgoing salary to attend the test), and psychosocial barriers to screening-such as poor knowledge and perceptions. 83, 84 Remoteness and rurality are associated with lower diagnostic test rates-likely due to geographic access to test sites, when compared with the home screening test. 85 Positive health beliefs and good health knowledge around CRC are associated with increased diagnostic testing, whilst those with a good attendance history from previous FOBT invitation are more likely to be followed up. 'Good health behaviours' do cluster in individuals; therefore this not surprising. That said, it is not clear whether knowledge about CRC leads to attendance, or whether the two share a common root cause. 86 A number of programme characteristics, all facets of organised screening programmes, are associated with higher diagnostic testing rates. These include performance feedback to primary care, dedicated funding for followup, patient tracking and automated results notification systems; whilst introducing guidelines improves testing rates. Similarly, without rigorous guidelines there can be a range of inappropriate reasons for clinicians not to refer patients. Studies report between 2 and 11% of those with a positive FOBT refuse diagnostic testing-with previous bad experiences of colonoscopy, embarrassment around the subject and notably the perception of pain the most consistent reasons. A range of interventions have been used to promote diagnostic testing. Using a screening specialist, either assigned to every positive FOBT result or after initially not responding to an invite, increases diagnostic testing rates. These overcome logistical barriers as well as offer counselling to patients-this can give support and information as 'cue' to attend. Introducing diagnostic testing guidelines, patient tracking systems and improving the quality of automated reminder systems also increase testing.
What is already known on this topic?
There is evidence of failures to follow-up test results in health care, with variation between settings and patient groups. 4 Similarly, colorectal screening has deficiencies in coverage with the completed screening regimen.
6 Disparities in uptake have been documented across types of screening, with lower coverage in low SEP and minority ethnic groups, amongst others. 87, 88 Screening programme characteristics are associated with improved uptake-notably facets of an organised programme, including recruitment strategies (systematic recruitment, follow-up, and appointments); personalised invitation and reducing structural barriers (location, timing of appointments, etc.). 89 Effective interventions to promote take-up of screening tests include clinician education, personal outreach and patient education. 90, 91 There are some general barriers to colonoscopy, with the laxative preparation; anxiety and anticipation of pain; embarrassment and inadequate knowledge major factors. 92 Cancelation of booked colonoscopy appointments shows similar patterns to those highlighted here: minority ethnic groups, older individuals and those with greater travel time were more likely to miss tests; as were those with limited life expectancy, no history of polyps, more time in between making and attending appointments and having 'opt-out' appointment systems. 93 
Limitations of this study
This systematic review has a number of limitations. Only one reviewer screened articles and extracted data; no a priori e54 JOURNAL OF PUBLIC HEALTH protocol was published; and it was not possible to combine effect estimates into a meta-analysis. The latter was due to variation in interventions. This study had wide inclusion criteria; therefore results cover a range of outcomes and study types. That said, this was done in order to capture a holistic view of diagnostic testing after a FOBT. It was not possible to assess study quality-again due to the variety of included studies, although generally studies had a number of limitations. Many interventions were evaluated using an observational methodology (time-series studies)-not a randomised study design-because studies evaluated real world interventions. Three interventions did not have their impact assessed. 55, 68, 72 Most studies used routine medical data, therefore are limited by the quality of reporting. Studies into underlying reasons behind incomplete diagnostic testing were frequently superficial, e.g. not using qualitative methods.
What this study adds
An organised and systematic screening programme increases diagnostic follow-up after a positive FOBT-improving many programme outputs. 94 Many constituent factors of such a programme, including notification systems, performance feedback and follow-up guidelines, improve diagnostic testing rates. If embarking on a CRC screening programme or working in existing programmes, these evidence based quality criteria should be adopted to maximise follow-up diagnostic testing. 95 Using a screening specialist-like the specialist practitioner used in the UK's BCSP-to guide the patient through the journey to colonoscopy is another important component. 96 Although non-attendance rates in those eligible are low, this is a high risk group with real and immediate need for the diagnostic testing. Critically, because these individuals have already undertaken the screening test, barriers must be diagnostic test or time specific. With the FOBT available as a home sample, physical barriers can still be importantindeed remoteness is shown here as a potential barrier. Access across geographies is therefore vital. Behaviour change in this group could very tangibly save their lives-by taking the diagnostic test.
8 Three further simple areas of intervention are likely to improve follow-up. Patient education and information overcomes misconceptions about the follow-up test, including perceived pain; imparts the health knowledge needed to understand the importance of this second test; and acts as a cue to action. This needs to be sensitive to differences in health literacy-which may reduce disparities by SEP. 97 Improving access to information through availability in different language may also reduce ethnic disparities. Two further practical strategies, offering alternate follow-up tests (to overcome genuine fear about colonoscopy) and flexible scheduling of appointments (to overcome competing priorities) may also promote completing the screening regimen. 98 
Conclusions
Rates of non-attendance in patients eligible for diagnostic testing are low after a positive FOBT/FIT but this does represent a group with a real health care need. Disparities, by SEP and ethnicity, must be eliminated in order to alleviate wider health inequity. Organised, high quality screening programmes can reduce drop out from screening, whilst efforts focused on accessible health information may also improve the complete journey through CRC screening using FOBT and FIT.
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